Suppr超能文献

中枢神经系统肿瘤中的增殖细胞核抗原和核仁组织区:与组织学类型和肿瘤分级的相关性。对82例石蜡切片病例的比较研究。

Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.

作者信息

Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E

机构信息

Department of Pathology, Asklepeion Hospital, Voula Attikis, Greece.

出版信息

Am J Surg Pathol. 1993 Sep;17(9):912-9. doi: 10.1097/00000478-199309000-00007.

Abstract

We investigated the expression of proliferating cell nuclear antigen (PCNA) and the number of nucleolar organizer regions (NORs) in 82 cases of CNS tumors. PCNA is a nuclear protein maximally elevated in the S phase of the cell cycle and recognized immunohistochemically in paraffin sections by the monoclonal antibody PC-10. On the other hand, NORs are loops of DNA that carry the rRNA genes and can be demonstrated in paraffin sections using an argyrophilic method (AgNORs). The present study shows a significant correlation of PCNA index and of AgNOR number with the histological grade (PCNA: I versus II, p < 0.01; II versus III, p < 0.01; and III versus IV, p < 0.05; AgNORs: I versus II, p < 0.001; II versus III, p < 0.05; and III versus IV, p < 0.001). Higher values of PCNA index (0.01 < p < 0.05) were found in recurrent tumors. Metastatic carcinomas were characterized by high PCNA indices and AgNOR numbers, similar to grade IV tumors, whereas in CNS lymphomas the malignancy grade was reflected in PCNA indices and AgNOR numbers. A wide range of PCNA and AgNOR values has been observed within each histological type and grade, probably reflecting variations in the biological behavior, but little overlap in PCNA values was present between grades II and III. The latter finding might be of importance in distinguishing between low- and high-grade CNS tumors. The linear regression coefficient between PCNA index and AgNOR number was excellent (0.91). We suggest that PCNA and AgNORs may be successfully applied in routine material to assess the growth potential of CNS tumors. Their prognostic value, however, must be validated with clinical studies.

摘要

我们研究了82例中枢神经系统肿瘤中增殖细胞核抗原(PCNA)的表达及核仁组织区(NORs)的数量。PCNA是一种在细胞周期S期水平最高的核蛋白,可通过单克隆抗体PC - 10在石蜡切片中进行免疫组织化学识别。另一方面,NORs是携带rRNA基因的DNA环,可通过嗜银法(AgNORs)在石蜡切片中显示。本研究表明,PCNA指数和AgNOR数量与组织学分级显著相关(PCNA:I级与II级,p < 0.01;II级与III级,p < 0.01;III级与IV级,p < 0.05;AgNORs:I级与II级,p < 0.001;II级与III级,p < 0.05;III级与IV级,p < 0.001)。复发性肿瘤中PCNA指数较高(0.01 < p < 0.05)。转移性癌的特征是PCNA指数和AgNOR数量较高,类似于IV级肿瘤,而在中枢神经系统淋巴瘤中,恶性程度反映在PCNA指数和AgNOR数量上。在每种组织学类型和分级中都观察到了广泛的PCNA和AgNOR值范围,这可能反映了生物学行为的差异,但II级和III级之间的PCNA值几乎没有重叠。后一发现可能对区分低级别和高级别中枢神经系统肿瘤具有重要意义。PCNA指数与AgNOR数量之间的线性回归系数极佳(0.91)。我们建议PCNA和AgNORs可成功应用于常规材料中,以评估中枢神经系统肿瘤的生长潜力。然而,它们的预后价值必须通过临床研究来验证。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验